Two-year outcome of an observe-and-plan regimen for neovascular age-related macular degeneration treated with Aflibercept
Crossref DOI link: https://doi.org/10.1007/s00417-017-3762-2
Published Online: 2017-08-10
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Parvin, Parmis
Zola, Marta
Dirani, Ali
Ambresin, Aude
Mantel, Irmela
License valid from 2017-08-10